Methods and compositions for oral delivery of Areca and mate' or theobromine
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-036/00
A61K-036/889
A61K-036/88
A61K-031/44
출원번호
US-0945378
(2004-09-20)
등록번호
US-7291352
(2007-11-06)
발명자
/ 주소
Gow,Robert T.
Pierce,John
Sypert,George W.
출원인 / 주소
HerbalScience LLC
대리인 / 주소
Troutman Sanders LLP
인용정보
피인용 횟수 :
1인용 특허 :
58
초록▼
The present invention comprises methods and compositions comprising Areca extract compositions and compositions comprising extracts of Ilex paraguariensis or theobromine. Methods of the invention comprise methods of making pharmaceutical or nutriceutical products comprising Areca catechu extract com
The present invention comprises methods and compositions comprising Areca extract compositions and compositions comprising extracts of Ilex paraguariensis or theobromine. Methods of the invention comprise methods of making pharmaceutical or nutriceutical products comprising Areca catechu extract compositions and mat챕 extract compositions or theobromine, and methods of use of the extracted products and pharmaceutical and nutriceutical products. The present invention also comprises methods for treating conditions related to mental and physical fatigue and obesity, as well as, enhancement of mental focus, cognition, and a sense of well being, comprising administering the compositions of the present invention.
대표청구항▼
What is claimed is: 1. A composition for enhancing memory, cognition, and sense of well being comprising an effective amount of a combination of: (a) an Areca catechu extract having an altered alkaloid profile comprising arecaidine and arecoline, wherein the concentration of arecaidine is greater t
What is claimed is: 1. A composition for enhancing memory, cognition, and sense of well being comprising an effective amount of a combination of: (a) an Areca catechu extract having an altered alkaloid profile comprising arecaidine and arecoline, wherein the concentration of arecaidine is greater than the concentration of arecoline therein, and (b) a mat챕 extract comprising theobromine and little or substantially no caffeine, wherein the concentration of caffeine is less that the concentration of theobromine therein. 2. The composition of claim 1, wherein in the Areca catechu extract comprises a greater amount of carboxy acid alkaloid compounds than ester alkaloid compounds therein. 3. The composition of claim 1, wherein the Areca catechu extract comprises substantially no arecoline. 4. The composition of claim 1, wherein the Areca catechu extract comprises substantially no tannin compounds. 5. The composition of claim 1, wherein the mat챕 extract comprises a caffeine concentration that is less than the caffeine concentration of native mat챕 plant material. 6. The composition of claim 1, wherein the mat챕 extract comprises a concentration of tannin compounds that is less that the concentration of tannin compounds found in native mat챕 plant material. 7. A method for enhancing memory, cognition, and sense of well being, comprising, administering to a human or animal an effective amount of a composition comprising a combination of: (a) an Areca catechu extract having an altered alkaloid profile comprising arecaidine and arecoline, wherein the concentration of arecaidine is greater than the concentration of arecoline therein, and (b) a mat챕 extract comprising theobromine and little or substantially no caffeine, wherein the concentration of caffeine is less that the concentration of theobromine therein. 8. The method of claim 7, wherein the Areca extract comprises alkaloid compounds in an amount between 0.5 mg and 300 mg. 9. The method of claim 7, wherein the Areca extract comprises arecaidine in an amount between 0.01 mg and 100 mg. 10. The method of claim 7, wherein the mat챕 extract comprises an amount between 0.1 mg and 750 mg. 11. The method of claim 7, wherein the is between 0.1 mg and 500 mg, and whereby the mat챕 extract has substantially no caffeine therein. 12. The method of claim 11, wherein the mat챕 extract further comprises substantially no tannin compounds. 13. The method of claim 11, and the amount of theobromine has been omitted and replaced with the phrase the amount of theobromine within the composition is between 0.1 mg and 500 mg. 14. A method for suppressing appetite and for treating obesity, comprising, administering to a human or animal an effective amount of a composition comprising a combination of: (a) an Areca catechu extract having an altered alkaloid profile comprising arecaidine and arecoline, wherein the concentration of arecaidine is greater than the concentration of arecoline therein, and (b) a mat챕 extract comprising theobromine and little or substantially no caffeine, wherein the concentration of caffeine is less that the concentration of theobromine therein. 15. The method of claim 14, wherein in the Areca catechu extract comprises a greater amount of carboxy acid alkaloid compounds than ester alkaloid compounds therein. 16. The method of claim 14, wherein the Areca catechu extract comprises substantially no arecoline. 17. The method of claim 14, wherein the Areca catechu extract comprises substantially no tannin compounds. 18. The method of claim 1, wherein the mat챕 extract comprises a caffeine concentration that is less than the caffeine concentration of native mat챕 plant material. 19. The method of claim 14, wherein the mat챕 extract comprises a tannin compounds concentration that is less than the tannin compounds concentration of native mat챕 plant material.
Keller Brian C. ; Fisher Daniel L. ; Kiss Steven, Delivery of biologically active material in a liposomal formulation for administration into the mouth.
Makooi-Morehead William T. ; Buehler John D. ; Landmann Brian R., Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants.
Wunderlich Jens-Christian (Heidelberg DEX) Schick Ursula (Wiesloch DEX) Freidenreich Jurgen (Schriesheim DEX) Werry Jurgen (Ludwigshafen DEX), Pellets containing plant extracts, process of making same and their pharmaceutical peroral or cosmetic use.
Huffstutler ; Jr. Miles C. (1608 W. 155th St. Burnsville MN 55306) Steuart Gary M. (P.O. Box 356 Harmony MN 55939), Polyphase fluid-extraction process, resulting products and methods of use.
Kreuter Matthias-H.,DEX ; Steiner Rudolf,CHX, Process for the preparation of a stable, homogeneous, extract free or nearly free from secondary reaction products.
Kreuter Mathias-Heinrich,CHX ; Steiner Rudolf,CHX, Process for the removal of undesired contaminations and/or residues contained in beverages or in vegetable preparation.
Kreuter Mathias-Heinrich,CHX ; Steiner Rudolf,CHX, Process for the removal of undesired lipophilic contaminations and/or residues, which are contained in beverages or in vegetable preparations.
Danysz Wojciech,DEX ; Gold Markus,DEX ; Kalvinsh Ivars,LVX ; Parsons Christopher Graham Raphael,DEX ; Piskunova Irene,LVX ; Rozhkov Eugene,LVX, Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning o.
Erdelmeier Clemens,DEX ; Grethlein Eckhart,DEX ; Lang Friedrich,DEX ; Oschmann Rainer,DEX ; Stumpf Karl-Heinz,DEX, Stable extract of Hypericum perforatum L.,process for preparing the same and pharmaceutical compositions.
Erdelmeier Clemens,DEX ; Grethlein Eckhart,DEX ; Lang Friedrich,DEX ; Oschmann Rainer,DEX ; Stumpf Karl-Heinz,DEX, Stable extract of hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations.
Castor Trevor P. ; Lander Arthur D. ; Cosman Maury David ; D'Entremont Peter Richard ; Pelletier Michael Richard, Viral inactivation method using near critical, supercritical or critical fluids.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.